New Hope For IGF-1 Cancer Treatments
Tuesday, November 27, 2012 - 10:03
in Health & Medicine
Various drugs companies have tried to produce antibodies that bind to the type 1 insulin-like growth factor, or IGF-1, receptor on the cell surface, which has a critical part to play in the development of cancer - but have had little success. Understanding more about how these antibodies work may help explain why only some cancer patients are helped by IGF-1 blockers during clinical tests. read more